Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Raphael Fraser

Showing results (11-20 of 28) with videos related to

Pageof 3
Sort By:
The Lancet. Haematology|April 29, 2018
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based studyBinod Dhakal, Lisa Baumann Kreuziger, Lisa Rein, et al.
Academic Pediatrics|February 1, 2019
Reported Knowledge and Management of Potential Penicillin Allergy in ChildrenDavid Vyles, Rakesh D Mistry, Viday Heffner, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2017
Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of AgeBinod Dhakal, Ariel Nelson, Guru Subramanian Guru Murthy, et al.
Vaccines|November 24, 2022
Understanding Influenza and SARS-CoV-2 Vaccine Hesitancy in Racial and Ethnic Minority CaregiversShannon H Baumer-Mouradian, Rebecca J Hart, Alexis Visotcky, et al.
Ebiomedicine|June 7, 2022
A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiomeJoseph Zenga, Samantha Atkinson, Tina Yen, et al.
British Journal of Haematology|March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy|March 29, 2021
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical TrialBart L Scott, Marcelo C Pasquini, Mingwei Fei, et al.
British Journal of Haematology|October 23, 2020
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myelomaBinod Dhakal, Anita D'Souza, Natalie Callander, et al.
Transplantation and Cellular Therapy|November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell TransplantationSurbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
Transplantation and Cellular Therapy|March 30, 2021
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell BurdenRobert F Cornell, Raphael Fraser, Luciano Costa, et al.
Pageof 3

Showing results (11-20 of 28) with videos related to

Sort By:
Pageof 3
The Lancet. Haematology|April 29, 2018
Disease burden, complication rates, and health-care costs of heparin-induced thrombocytopenia in the USA: a population-based studyBinod Dhakal, Lisa Baumann Kreuziger, Lisa Rein, et al.
Academic Pediatrics|February 1, 2019
Reported Knowledge and Management of Potential Penicillin Allergy in ChildrenDavid Vyles, Rakesh D Mistry, Viday Heffner, et al.
Clinical Lymphoma, Myeloma & Leukemia|February 5, 2017
Autologous Hematopoietic Cell Transplantation in Patients With Multiple Myeloma: Effect of AgeBinod Dhakal, Ariel Nelson, Guru Subramanian Guru Murthy, et al.
Vaccines|November 24, 2022
Understanding Influenza and SARS-CoV-2 Vaccine Hesitancy in Racial and Ethnic Minority CaregiversShannon H Baumer-Mouradian, Rebecca J Hart, Alexis Visotcky, et al.
Ebiomedicine|June 7, 2022
A phase 2 trial of a topical antiseptic bundle in head and neck cancer surgery: Effects on surgical site infection and the oral microbiomeJoseph Zenga, Samantha Atkinson, Tina Yen, et al.
British Journal of Haematology|March 14, 2022
Does recipient body mass index inform donor selection for allogeneic haematopoietic cell transplantation?Mouhamed Yazan Abou-Ismail, Raphael Fraser, Mariam Allbee-Johnson, et al.
Transplantation and Cellular Therapy|March 29, 2021
Myeloablative versus Reduced-Intensity Conditioning for Hematopoietic Cell Transplantation in Acute Myelogenous Leukemia and Myelodysplastic Syndromes-Long-Term Follow-Up of the BMT CTN 0901 Clinical TrialBart L Scott, Marcelo C Pasquini, Mingwei Fei, et al.
British Journal of Haematology|October 23, 2020
Novel prognostic scoring system for autologous hematopoietic cell transplantation in multiple myelomaBinod Dhakal, Anita D'Souza, Natalie Callander, et al.
Transplantation and Cellular Therapy|November 15, 2021
Impact of Induction Therapy with VRD versus VCD on Outcomes in Patients with Multiple Myeloma in Partial Response or Better Undergoing Upfront Autologous Stem Cell TransplantationSurbhi Sidana, Shaji Kumar, Raphael Fraser, et al.
Transplantation and Cellular Therapy|March 30, 2021
Bortezomib-Based Induction Is Associated with Superior Outcomes in Light Chain Amyloidosis Patients Treated with Autologous Hematopoietic Cell Transplantation Regardless of Plasma Cell BurdenRobert F Cornell, Raphael Fraser, Luciano Costa, et al.
Pageof 3